Enterprise software maker C3 AI said founder Thomas M. Siebel plans to relinquish the chief executive post because of eyesight problems stemming from an autoimmune disease. Siebel, 72, will stay on until a successor is appointed and then move to the role of executive chairman, where he will concentrate on long-term strategy. The board has formed a management committee and hired an international executive-search firm to lead the recruitment process. No timeline for the handover was disclosed. C3 AI shares dropped roughly 7% in early New York trading after the announcement. Wedbush Securities called the transition a near-term negative but said it could accelerate takeover interest in the company; the broker reiterated its Outperform rating and $35 price target.
Software company https://t.co/1VxxxoPRcn is looking for a new chief executive officer after Tom Siebel said he intends to step aside due to health concerns https://t.co/fZlcz9AGRF
Just in: Wedbush views C3 AI's $AI CEO transition as a net negative, increasing M&A chances. Founder Tom Siebel steps down due to health issues. C3 AI seen as a top M&A target in the AI space. Wedbush maintains Outperform rating with a $35 price target.
Just in: C3 AI $AI has started the search for a successor to CEO Thomas Siebel. An internationally renowned search firm will assist, reporting to a board and management committee.